These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 19132197

  • 1. Functional variability of platelet response to clopidogrel correlates with P2Y(12) receptor occupancy.
    Bal Dit Sollier C, Berge N, Boval B, Hovsepian L, Drouet L.
    Thromb Haemost; 2009 Jan; 101(1):116-22. PubMed ID: 19132197
    [Abstract] [Full Text] [Related]

  • 2. Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel.
    Bal Dit Sollier C, Berge N, Boval B, Dubar M, Drouet L.
    Thromb Haemost; 2010 Sep; 104(3):571-81. PubMed ID: 20664906
    [Abstract] [Full Text] [Related]

  • 3. Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability.
    Wong PC, Crain EJ, Watson CA, Hua J, Schumacher WA, Rehfuss R.
    Thromb Haemost; 2009 Jan; 101(1):108-15. PubMed ID: 19132196
    [Abstract] [Full Text] [Related]

  • 4. How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.
    Neubauer H, Lask S, Engelhardt A, Mügge A.
    Thromb Haemost; 2008 Feb; 99(2):357-62. PubMed ID: 18278186
    [Abstract] [Full Text] [Related]

  • 5. Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.
    Wong PC, Crain EJ, Watson CA, Jiang X, Hua J, Bostwick JS, Ogletree ML, Schumacher WA, Rehfuss R.
    J Cardiovasc Pharmacol; 2007 May; 49(5):316-24. PubMed ID: 17513951
    [Abstract] [Full Text] [Related]

  • 6. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation.
    Brandt JT, Payne CD, Wiviott SD, Weerakkody G, Farid NA, Small DS, Jakubowski JA, Naganuma H, Winters KJ.
    Am Heart J; 2007 Jan; 153(1):66.e9-16. PubMed ID: 17174640
    [Abstract] [Full Text] [Related]

  • 7. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
    Lepäntalo A, Virtanen KS, Reséndiz JC, Mikkelsson J, Viiri LE, Karhunen PJ, Lassila R.
    Thromb Res; 2009 Jun; 124(2):193-8. PubMed ID: 19232433
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry.
    Jakubowski JA, Payne CD, Li YG, Farid NA, Brandt JT, Small DS, Salazar DE, Winters KJ.
    Thromb Haemost; 2008 Jan; 99(1):215-22. PubMed ID: 18217157
    [Abstract] [Full Text] [Related]

  • 9. ADP-induced platelet aggregation frequently fails to detect impaired clopidogrel-responsiveness in patients with coronary artery disease compared to a P2Y12-specific assay.
    Schäfer A, Weinberger S, Flierl U, Eigenthaler M, Störk S, Walter U, Ertl G, Bauersachs J.
    Thromb Haemost; 2008 Oct; 100(4):618-25. PubMed ID: 18841284
    [Abstract] [Full Text] [Related]

  • 10. Increased active metabolite formation explains the greater platelet inhibition with prasugrel compared to high-dose clopidogrel.
    Payne CD, Li YG, Small DS, Ernest CS, Farid NA, Jakubowski JA, Brandt JT, Salazar DE, Winters KJ.
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):555-62. PubMed ID: 18030066
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease.
    Storey RF, Wilcox RG, Heptinstall S.
    Platelets; 2002 Nov; 13(7):407-13. PubMed ID: 12487788
    [Abstract] [Full Text] [Related]

  • 12. Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel.
    Lev EI, Patel RT, Guthikonda S, Lopez D, Bray PF, Kleiman NS.
    Thromb Res; 2007 Nov; 119(3):355-60. PubMed ID: 16581111
    [Abstract] [Full Text] [Related]

  • 13. Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.
    Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Cavallari U, Trabetti E, Sabaté M, Jimenez-Quevedo P, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C.
    Thromb Res; 2005 Nov; 116(6):491-7. PubMed ID: 16181985
    [Abstract] [Full Text] [Related]

  • 14. Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: an integrated analysis.
    Weerakkody GJ, Jakubowski JA, Brandt JT, Payne CD, Naganuma H, Winters KJ.
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):205-12. PubMed ID: 17875947
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients.
    Angiolillo DJ, Capranzano P, Desai B, Shoemaker SB, Charlton R, Zenni MM, Guzman LA, Bass TA.
    Thromb Res; 2009 Jul; 124(3):318-22. PubMed ID: 19012950
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.